Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2012 FY- Text added to 2013 FY
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
8th grade Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
8th grade Avg
|
New words:
add, advertize, analytic, avoid, break, buy, buyer, calledchemokine, Castaldo, channel, Christopher, club, companion, dietetic, dimethylsulfoxide, DMSO, dysplasia, epidemic, equine, Facebook, filming, formula, France, gauge, GBI, Germany, hip, Immunoclin, Indian, infomercial, IPO, Italy, Japan, Lakeside, lesser, lump, mutual, MyNyloxin, necessity, newest, newly, Nyloxin®, Nyloxin®are, Nyloxin®Extra, Nyloxin®Military, ofthe, opportunity, overhaul, perpetuity, Pet, piece, portal, pric, ran, relocated, salary, saving, shipment, shoot, Spain, TheEquine, True, underwriting, Village, Vitality
Valuein 2012 FY filing- Value in 2013 FY filing
Original filings
Filing view